Key Record Dates
ClinicalTrials.gov Identifier: | NCT03601078 |
---|---|
Brief Title: | An Efficacy and Safety Study of bb2121 in Subjects With Relapsed and Refractory Multiple Myeloma and in Subjects With High-Risk Multiple Myeloma (KarMMa-2) |
First Submitted : | July 17, 2018 |
First Submitted that Met QC Criteria : | July 17, 2018 |
First Posted : | July 26, 2018 |
Last Update Submitted that Met QC Criteria : | October 15, 2020 |
Last Update Posted : | October 19, 2020 |